CN Stock MarketDetailed Quotes

688505 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Watchlist
  • 8.54
  • -0.16-1.84%
Market Closed Nov 1 15:00 CST
8.85BMarket Cap84.55P/E (TTM)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-16.41%1.04B
-0.70%1.22B
38.89%1.23B
-7.24%1.2B
0.43%1.24B
2.03%1.23B
-22.76%888.01M
6.65%1.29B
34.55%1.24B
7.89%1.21B
Transactional financial assets
----
----
----
----
----
----
--190M
----
----
----
Notes receivable and accounts receivable
-19.35%524.88M
-23.54%565.88M
-20.73%535.19M
-8.63%620.49M
-7.61%650.8M
42.14%740.09M
8.50%675.14M
0.99%679.12M
27.17%704.44M
-3.74%520.69M
-Notes receivable
-0.55%125.95M
17.41%117.53M
-36.42%83.18M
0.88%174.26M
7.22%126.65M
21.73%100.1M
27.68%130.83M
46.23%172.74M
26.62%118.12M
-35.23%82.23M
-Accounts receivable
-23.89%398.93M
-29.94%448.35M
-16.96%452.01M
-11.88%446.22M
-10.60%524.15M
45.96%639.99M
4.72%544.32M
-8.65%506.38M
27.29%586.32M
5.92%438.46M
Other receivables (including interest and dividends)
-30.91%3.3M
-23.39%3.63M
-40.90%3.36M
-27.33%3.54M
0.12%4.77M
5.65%4.73M
24.70%5.68M
22.99%4.87M
19.11%4.77M
27.99%4.48M
-Other receivable
----
-23.39%3.63M
----
-27.33%3.54M
----
5.65%4.73M
----
22.99%4.87M
----
27.99%4.48M
Advance payment
445.41%34.48M
127.87%20.38M
70.43%11.57M
-75.92%4.33M
-53.01%6.32M
-10.83%8.95M
-26.59%6.79M
202.46%17.99M
20.86%13.45M
-17.28%10.03M
Inventories
14.75%47.2M
6.39%52.71M
-5.82%46.92M
7.71%43.65M
17.86%41.13M
17.82%49.55M
16.02%49.82M
13.76%40.53M
-13.10%34.89M
2.36%42.05M
Non-current assets due within one year
----
----
----
----
----
----
--33.63M
--33.32M
----
----
Other current assets
82.10%8.38M
-47.89%4.52M
-80.46%2.89M
-62.49%1.52M
1,308.05%4.6M
3,410.80%8.68M
662.51%14.8M
288.05%4.06M
-21.89%326.92K
-29.47%247.32K
Adjustment items of current assets
--1
----
----
----
----
----
----
----
----
----
Total current assets
-15.04%1.66B
-8.49%1.87B
-1.64%1.83B
-9.65%1.87B
-2.25%1.95B
14.52%2.04B
1.81%1.86B
7.33%2.07B
14.71%2B
3.95%1.78B
Non Current assets
Other equity investment
-95.29%17.21K
-93.39%24.24K
-96.96%9.29K
-97.50%15.13K
-24.34%365.25K
-68.78%366.68K
-80.90%305.36K
-70.48%604.24K
-86.25%482.76K
-87.28%1.17M
Long term receivable account
--991.22K
--991.22K
--958.5K
--958.5K
----
----
----
----
----
----
Fixed assets
----
138.32%491.65M
----
10.78%228.5M
----
-1.32%206.3M
----
-7.46%206.26M
----
-5.07%209.05M
Constru in process
----
-99.89%187.19K
----
87.92%229.96M
----
72.59%169.08M
----
150.25%122.37M
----
1,924.70%97.97M
Intangible assets
27.32%74.32M
33.72%79.57M
36.63%83.06M
38.56%86.35M
-29.48%58.37M
-29.21%59.5M
-29.61%60.79M
-29.54%62.32M
-2.33%82.78M
-3.32%84.06M
Development expenditure
-97.41%921.68K
-97.92%737.61K
-98.42%556.78K
----
4.73%35.61M
9.78%35.46M
20.22%35.21M
24.30%34.83M
20.08%34M
74.73%32.3M
Long deferred expense
-19.61%5.08M
9.92%7.62M
3.50%8.54M
37.06%11.32M
-21.86%6.33M
-14.32%6.93M
-1.61%8.26M
2.01%8.26M
10.41%8.09M
481.37%8.09M
Deferred tax assets
8.90%101.54M
8.57%99.4M
10.03%101.8M
17.43%100.87M
8.35%93.25M
-12.35%91.56M
7.49%92.52M
8.43%85.9M
13.36%86.06M
70.58%104.46M
Usufruct assets
-34.37%11.03M
-32.66%12.68M
-30.50%14.69M
-26.26%16.87M
-32.53%16.81M
-30.14%18.83M
-25.00%21.14M
-24.09%22.88M
-21.91%24.92M
20.61%26.96M
Other non current assets
-90.31%7.46M
-93.03%7.01M
-55.43%45.34M
-22.09%44.89M
98.60%77.01M
217.70%100.51M
256.38%101.73M
193.35%57.62M
61.56%38.78M
132.49%31.64M
Adjustment items of non current assets
--1
----
----
----
----
----
----
----
----
----
Total non current assets
-2.57%970.35M
-0.89%979.09M
0.56%992.03M
11.08%1.01B
9.03%995.93M
7.64%987.88M
11.71%986.47M
6.28%906.82M
13.62%913.45M
20.30%917.8M
Total assets
-10.82%2.63B
-6.02%2.85B
-0.88%2.83B
-3.34%2.88B
1.29%2.95B
12.18%3.03B
5.03%2.85B
7.01%2.98B
14.37%2.91B
8.98%2.7B
Liabilities
Current liabilities
Short term loan
----
----
----
----
--100M
--100M
--101M
--101M
----
----
Notes payable and accounts payable
69.03%12.87M
56.68%13.87M
-25.45%7.39M
8.39%8.05M
-11.81%7.61M
-33.67%8.85M
-29.46%9.91M
-9.00%7.43M
60.87%8.63M
137.89%13.34M
-Accounts payable
69.03%12.87M
56.68%13.87M
-25.45%7.39M
8.39%8.05M
-11.81%7.61M
-33.67%8.85M
-29.46%9.91M
-9.00%7.43M
60.87%8.63M
137.89%13.34M
Contract liabilities
-1.73%366.31K
88.51%481.05K
11.47%316.09K
-15.60%260.74K
60.33%372.78K
44.25%255.19K
-69.71%283.57K
-72.34%308.92K
-65.44%232.5K
-84.63%176.91K
Salaries payable
-91.91%1.65M
-17.47%16.72M
-52.65%962.78K
-9.64%25.08M
-13.86%20.37M
540.29%20.26M
-61.25%2.03M
-23.93%27.76M
-22.45%23.65M
-87.39%3.16M
Taxs payable
-86.25%1.37M
55.85%14.56M
276.55%8.06M
26.93%12.2M
-58.88%9.96M
-0.69%9.34M
-84.87%2.14M
-67.66%9.61M
110.13%24.22M
-31.18%9.41M
Other payable (including interest and dividends)
-41.97%246.49M
-17.97%432.36M
2.83%431.37M
-12.70%453.06M
-26.43%424.75M
8.25%527.09M
-0.02%419.48M
16.89%518.97M
62.75%577.31M
42.68%486.9M
-Dividend payable
--2.16M
--72.56M
----
----
----
----
----
--1.34M
----
323.71%72.03M
-Other payable
----
----
----
-12.48%453.06M
----
--527.09M
----
--517.63M
----
----
Non current liabilities due within one year
-54.45%3.01M
-60.05%3.24M
-37.00%4.91M
-22.97%6.33M
-21.78%6.6M
-6.73%8.11M
-9.35%7.79M
-5.29%8.22M
0.18%8.44M
97.01%8.7M
Other current liabilities
-1.73%47.62K
88.50%62.54K
11.47%41.09K
-15.60%33.9K
60.33%48.46K
44.26%33.18K
59.75%36.87K
-13.76%40.16K
--30.23K
--23K
Total current liabilities
-53.35%265.8M
-28.59%481.3M
-16.52%453.05M
-25.00%505.02M
-11.33%569.71M
29.18%673.95M
17.32%542.67M
27.48%673.34M
56.25%642.52M
33.37%521.72M
Current liabilities
Long term deferred income
-98.57%414.83K
-96.78%994.08K
-95.12%1.57M
-93.68%2.15M
-18.84%29.1M
-17.94%30.91M
-17.33%32.23M
-16.56%34.04M
-15.85%35.85M
-15.21%37.66M
Lease liabilities
-20.55%8.29M
-19.70%8.98M
-26.71%9.87M
-29.78%10.95M
-39.59%10.43M
-43.85%11.19M
-35.45%13.47M
-30.94%15.6M
-29.75%17.26M
8.75%19.92M
Total non current liabilities
-77.99%8.7M
-76.30%9.98M
-74.96%11.44M
-73.60%13.11M
-25.59%39.53M
-26.90%42.09M
-23.64%45.7M
-21.68%49.64M
-20.94%53.12M
-8.21%57.58M
Total liabilities
-54.94%274.5M
-31.39%491.27M
-21.05%464.49M
-28.34%518.12M
-12.42%609.24M
23.60%716.04M
12.63%588.37M
22.21%722.99M
45.41%695.64M
27.62%579.3M
Shareholders equity
Paid-in capital
0.00%103.66M
0.00%103.66M
0.74%103.66M
0.74%103.66M
0.74%103.66M
0.74%103.66M
-1.34%102.9M
-1.34%102.9M
-1.34%102.9M
-1.34%102.9M
Capital reserve funds
0.39%1.29B
-0.00%1.29B
5.20%1.29B
5.25%1.29B
0.02%1.29B
1.80%1.29B
-2.93%1.23B
-3.17%1.23B
5.02%1.29B
5.61%1.27B
Surplus reserve funds
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
0.00%52.15M
Retained profit
1.32%911.49M
4.34%916.22M
3.33%920.66M
4.09%918.31M
15.17%899.58M
23.98%878.12M
8.50%891.03M
8.08%882.24M
8.24%781.07M
5.95%708.27M
Other composite income
-14.03%-6.08M
-7.70%-5.72M
-5.07%-5.83M
-12.64%-5.86M
-1.48%-5.33M
-11.61%-5.31M
-22.89%-5.55M
-28.39%-5.2M
-107.56%-5.26M
-249.73%-4.76M
Shareholders equity without minority interests
0.70%2.35B
1.62%2.36B
4.14%2.36B
4.45%2.36B
5.39%2.34B
9.07%2.32B
3.25%2.27B
2.93%2.26B
7.18%2.22B
4.82%2.13B
Minority interests
-35.62%712.48K
122.50%880.47K
122.63%922K
124.74%1.01M
132.17%1.11M
-15.03%-3.91M
-17.34%-4.07M
-21.60%-4.08M
-9.96%-3.44M
-19.09%-3.4M
Total shareholder equity
0.68%2.35B
1.83%2.36B
4.37%2.36B
4.68%2.36B
5.60%2.34B
9.06%2.31B
3.22%2.26B
2.90%2.25B
7.18%2.21B
4.80%2.12B
Total liabilityies and equity
-10.82%2.63B
-6.02%2.85B
-0.88%2.83B
-3.34%2.88B
1.29%2.95B
12.18%3.03B
5.03%2.85B
7.01%2.98B
14.37%2.91B
8.98%2.7B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -16.41%1.04B-0.70%1.22B38.89%1.23B-7.24%1.2B0.43%1.24B2.03%1.23B-22.76%888.01M6.65%1.29B34.55%1.24B7.89%1.21B
Transactional financial assets --------------------------190M------------
Notes receivable and accounts receivable -19.35%524.88M-23.54%565.88M-20.73%535.19M-8.63%620.49M-7.61%650.8M42.14%740.09M8.50%675.14M0.99%679.12M27.17%704.44M-3.74%520.69M
-Notes receivable -0.55%125.95M17.41%117.53M-36.42%83.18M0.88%174.26M7.22%126.65M21.73%100.1M27.68%130.83M46.23%172.74M26.62%118.12M-35.23%82.23M
-Accounts receivable -23.89%398.93M-29.94%448.35M-16.96%452.01M-11.88%446.22M-10.60%524.15M45.96%639.99M4.72%544.32M-8.65%506.38M27.29%586.32M5.92%438.46M
Other receivables (including interest and dividends) -30.91%3.3M-23.39%3.63M-40.90%3.36M-27.33%3.54M0.12%4.77M5.65%4.73M24.70%5.68M22.99%4.87M19.11%4.77M27.99%4.48M
-Other receivable -----23.39%3.63M-----27.33%3.54M----5.65%4.73M----22.99%4.87M----27.99%4.48M
Advance payment 445.41%34.48M127.87%20.38M70.43%11.57M-75.92%4.33M-53.01%6.32M-10.83%8.95M-26.59%6.79M202.46%17.99M20.86%13.45M-17.28%10.03M
Inventories 14.75%47.2M6.39%52.71M-5.82%46.92M7.71%43.65M17.86%41.13M17.82%49.55M16.02%49.82M13.76%40.53M-13.10%34.89M2.36%42.05M
Non-current assets due within one year --------------------------33.63M--33.32M--------
Other current assets 82.10%8.38M-47.89%4.52M-80.46%2.89M-62.49%1.52M1,308.05%4.6M3,410.80%8.68M662.51%14.8M288.05%4.06M-21.89%326.92K-29.47%247.32K
Adjustment items of current assets --1------------------------------------
Total current assets -15.04%1.66B-8.49%1.87B-1.64%1.83B-9.65%1.87B-2.25%1.95B14.52%2.04B1.81%1.86B7.33%2.07B14.71%2B3.95%1.78B
Non Current assets
Other equity investment -95.29%17.21K-93.39%24.24K-96.96%9.29K-97.50%15.13K-24.34%365.25K-68.78%366.68K-80.90%305.36K-70.48%604.24K-86.25%482.76K-87.28%1.17M
Long term receivable account --991.22K--991.22K--958.5K--958.5K------------------------
Fixed assets ----138.32%491.65M----10.78%228.5M-----1.32%206.3M-----7.46%206.26M-----5.07%209.05M
Constru in process -----99.89%187.19K----87.92%229.96M----72.59%169.08M----150.25%122.37M----1,924.70%97.97M
Intangible assets 27.32%74.32M33.72%79.57M36.63%83.06M38.56%86.35M-29.48%58.37M-29.21%59.5M-29.61%60.79M-29.54%62.32M-2.33%82.78M-3.32%84.06M
Development expenditure -97.41%921.68K-97.92%737.61K-98.42%556.78K----4.73%35.61M9.78%35.46M20.22%35.21M24.30%34.83M20.08%34M74.73%32.3M
Long deferred expense -19.61%5.08M9.92%7.62M3.50%8.54M37.06%11.32M-21.86%6.33M-14.32%6.93M-1.61%8.26M2.01%8.26M10.41%8.09M481.37%8.09M
Deferred tax assets 8.90%101.54M8.57%99.4M10.03%101.8M17.43%100.87M8.35%93.25M-12.35%91.56M7.49%92.52M8.43%85.9M13.36%86.06M70.58%104.46M
Usufruct assets -34.37%11.03M-32.66%12.68M-30.50%14.69M-26.26%16.87M-32.53%16.81M-30.14%18.83M-25.00%21.14M-24.09%22.88M-21.91%24.92M20.61%26.96M
Other non current assets -90.31%7.46M-93.03%7.01M-55.43%45.34M-22.09%44.89M98.60%77.01M217.70%100.51M256.38%101.73M193.35%57.62M61.56%38.78M132.49%31.64M
Adjustment items of non current assets --1------------------------------------
Total non current assets -2.57%970.35M-0.89%979.09M0.56%992.03M11.08%1.01B9.03%995.93M7.64%987.88M11.71%986.47M6.28%906.82M13.62%913.45M20.30%917.8M
Total assets -10.82%2.63B-6.02%2.85B-0.88%2.83B-3.34%2.88B1.29%2.95B12.18%3.03B5.03%2.85B7.01%2.98B14.37%2.91B8.98%2.7B
Liabilities
Current liabilities
Short term loan ------------------100M--100M--101M--101M--------
Notes payable and accounts payable 69.03%12.87M56.68%13.87M-25.45%7.39M8.39%8.05M-11.81%7.61M-33.67%8.85M-29.46%9.91M-9.00%7.43M60.87%8.63M137.89%13.34M
-Accounts payable 69.03%12.87M56.68%13.87M-25.45%7.39M8.39%8.05M-11.81%7.61M-33.67%8.85M-29.46%9.91M-9.00%7.43M60.87%8.63M137.89%13.34M
Contract liabilities -1.73%366.31K88.51%481.05K11.47%316.09K-15.60%260.74K60.33%372.78K44.25%255.19K-69.71%283.57K-72.34%308.92K-65.44%232.5K-84.63%176.91K
Salaries payable -91.91%1.65M-17.47%16.72M-52.65%962.78K-9.64%25.08M-13.86%20.37M540.29%20.26M-61.25%2.03M-23.93%27.76M-22.45%23.65M-87.39%3.16M
Taxs payable -86.25%1.37M55.85%14.56M276.55%8.06M26.93%12.2M-58.88%9.96M-0.69%9.34M-84.87%2.14M-67.66%9.61M110.13%24.22M-31.18%9.41M
Other payable (including interest and dividends) -41.97%246.49M-17.97%432.36M2.83%431.37M-12.70%453.06M-26.43%424.75M8.25%527.09M-0.02%419.48M16.89%518.97M62.75%577.31M42.68%486.9M
-Dividend payable --2.16M--72.56M----------------------1.34M----323.71%72.03M
-Other payable -------------12.48%453.06M------527.09M------517.63M--------
Non current liabilities due within one year -54.45%3.01M-60.05%3.24M-37.00%4.91M-22.97%6.33M-21.78%6.6M-6.73%8.11M-9.35%7.79M-5.29%8.22M0.18%8.44M97.01%8.7M
Other current liabilities -1.73%47.62K88.50%62.54K11.47%41.09K-15.60%33.9K60.33%48.46K44.26%33.18K59.75%36.87K-13.76%40.16K--30.23K--23K
Total current liabilities -53.35%265.8M-28.59%481.3M-16.52%453.05M-25.00%505.02M-11.33%569.71M29.18%673.95M17.32%542.67M27.48%673.34M56.25%642.52M33.37%521.72M
Current liabilities
Long term deferred income -98.57%414.83K-96.78%994.08K-95.12%1.57M-93.68%2.15M-18.84%29.1M-17.94%30.91M-17.33%32.23M-16.56%34.04M-15.85%35.85M-15.21%37.66M
Lease liabilities -20.55%8.29M-19.70%8.98M-26.71%9.87M-29.78%10.95M-39.59%10.43M-43.85%11.19M-35.45%13.47M-30.94%15.6M-29.75%17.26M8.75%19.92M
Total non current liabilities -77.99%8.7M-76.30%9.98M-74.96%11.44M-73.60%13.11M-25.59%39.53M-26.90%42.09M-23.64%45.7M-21.68%49.64M-20.94%53.12M-8.21%57.58M
Total liabilities -54.94%274.5M-31.39%491.27M-21.05%464.49M-28.34%518.12M-12.42%609.24M23.60%716.04M12.63%588.37M22.21%722.99M45.41%695.64M27.62%579.3M
Shareholders equity
Paid-in capital 0.00%103.66M0.00%103.66M0.74%103.66M0.74%103.66M0.74%103.66M0.74%103.66M-1.34%102.9M-1.34%102.9M-1.34%102.9M-1.34%102.9M
Capital reserve funds 0.39%1.29B-0.00%1.29B5.20%1.29B5.25%1.29B0.02%1.29B1.80%1.29B-2.93%1.23B-3.17%1.23B5.02%1.29B5.61%1.27B
Surplus reserve funds 0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M0.00%52.15M
Retained profit 1.32%911.49M4.34%916.22M3.33%920.66M4.09%918.31M15.17%899.58M23.98%878.12M8.50%891.03M8.08%882.24M8.24%781.07M5.95%708.27M
Other composite income -14.03%-6.08M-7.70%-5.72M-5.07%-5.83M-12.64%-5.86M-1.48%-5.33M-11.61%-5.31M-22.89%-5.55M-28.39%-5.2M-107.56%-5.26M-249.73%-4.76M
Shareholders equity without minority interests 0.70%2.35B1.62%2.36B4.14%2.36B4.45%2.36B5.39%2.34B9.07%2.32B3.25%2.27B2.93%2.26B7.18%2.22B4.82%2.13B
Minority interests -35.62%712.48K122.50%880.47K122.63%922K124.74%1.01M132.17%1.11M-15.03%-3.91M-17.34%-4.07M-21.60%-4.08M-9.96%-3.44M-19.09%-3.4M
Total shareholder equity 0.68%2.35B1.83%2.36B4.37%2.36B4.68%2.36B5.60%2.34B9.06%2.31B3.22%2.26B2.90%2.25B7.18%2.21B4.80%2.12B
Total liabilityies and equity -10.82%2.63B-6.02%2.85B-0.88%2.83B-3.34%2.88B1.29%2.95B12.18%3.03B5.03%2.85B7.01%2.98B14.37%2.91B8.98%2.7B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data